116 related articles for article (PubMed ID: 28102234)
1. Heart failure: Recombinant neuregulin for HF treatment.
Ummarino D
Nat Rev Cardiol; 2017 Mar; 14(3):128. PubMed ID: 28102234
[No Abstract] [Full Text] [Related]
2. Assessment of Complementary Treatment with Yiqi Fumai Lyophilized Injection on Acute Decompensated Ischemic Heart Failure (ACT-ADIHF): Rationale and Design of a Multicenter, Randomized, Controlled Trial.
Wang X; Zhao Z; Hou Y; Tang E; Zhao G; Wang S; Bi Y; Zhong C; Ren M; Zhang J; Mao J; Zhang B
Cardiovasc Drugs Ther; 2018 Jun; 32(3):295-300. PubMed ID: 29713851
[TBL] [Abstract][Full Text] [Related]
3. Effects of Statin Treatment on Inflammation and Cardiac Function in Heart Failure: An Adjusted Indirect Comparison Meta-Analysis of Randomized Trials.
Bonsu KO; Reidpath DD; Kadirvelu A
Cardiovasc Ther; 2015 Dec; 33(6):338-46. PubMed ID: 26280110
[TBL] [Abstract][Full Text] [Related]
4. Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy.
Shen L; Ramires F; Martinez F; Bodanese LC; Echeverría LE; Gómez EA; Abraham WT; Dickstein K; Køber L; Packer M; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Jhund PS; Gimpelewicz CR; McMurray JJV;
Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29141857
[TBL] [Abstract][Full Text] [Related]
5. Adenosine A1 receptor antagonists at a fork in the road.
Givertz MM
Circ Heart Fail; 2009 Nov; 2(6):519-22. PubMed ID: 19919975
[No Abstract] [Full Text] [Related]
6. Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses.
Jabbour A; Hayward CS; Keogh AM; Kotlyar E; McCrohon JA; England JF; Amor R; Liu X; Li XY; Zhou MD; Graham RM; Macdonald PS
Eur J Heart Fail; 2011 Jan; 13(1):83-92. PubMed ID: 20810473
[TBL] [Abstract][Full Text] [Related]
7. Management of chronic congestive heart failure: Part I--General introduction to treatment.
Kayser SR
Prog Cardiovasc Nurs; 1994; 9(1):39-42. PubMed ID: 8058693
[No Abstract] [Full Text] [Related]
8. Novel Mitochondria-Targeting Peptide in Heart Failure Treatment: A Randomized, Placebo-Controlled Trial of Elamipretide.
Daubert MA; Yow E; Dunn G; Marchev S; Barnhart H; Douglas PS; O'Connor C; Goldstein S; Udelson JE; Sabbah HN
Circ Heart Fail; 2017 Dec; 10(12):. PubMed ID: 29217757
[TBL] [Abstract][Full Text] [Related]
9. Chronic Neuregulin-1β Treatment Mitigates the Progression of Postmyocardial Infarction Heart Failure in the Setting of Type 1 Diabetes Mellitus by Suppressing Myocardial Apoptosis, Fibrosis, and Key Oxidant-Producing Enzymes.
Gupte M; Lal H; Ahmad F; Sawyer DB; Hill MF
J Card Fail; 2017 Dec; 23(12):887-899. PubMed ID: 28870731
[TBL] [Abstract][Full Text] [Related]
10. Letter by Nguyen and Doenst regarding article "Chronic glucagon-like peptide-1 infusion sustains left ventricular systolic function and prolongs survival in the spontaneously hypertensive, heart-failure prone rat".
Nguyen TD; Doenst T
Circ Heart Fail; 2009 May; 2(3):e1; author reply e2. PubMed ID: 19808332
[No Abstract] [Full Text] [Related]
11. Ivabradine in Children With Dilated Cardiomyopathy and Symptomatic Chronic Heart Failure.
Bonnet D; Berger F; Jokinen E; Kantor PF; Daubeney PEF
J Am Coll Cardiol; 2017 Sep; 70(10):1262-1272. PubMed ID: 28859790
[TBL] [Abstract][Full Text] [Related]
12. [Diastolic heart failure. Pathophysiology, diagnosis and therapy].
von Scheidt W
Med Klin (Munich); 1996 Jan; 91(1):28-35. PubMed ID: 8839198
[No Abstract] [Full Text] [Related]
13. Clinical assessment of Shenfu injection loading in the treatment of patients with exacerbation of chronic heart failure due to coronary heart disease: study protocol for a randomized controlled trial.
Liu C; Hou Y; Wang X; Zhao Z; Liu Z; Zhai J; Mao J; Shang H
Trials; 2015 May; 16():222. PubMed ID: 25994188
[TBL] [Abstract][Full Text] [Related]
14. MY APPROACH to the patient with heart failure and improved ejection fraction
Cohn JN
Trends Cardiovasc Med; 2018 Feb; 28(2):153. PubMed ID: 29032935
[No Abstract] [Full Text] [Related]
15. Therapy of left ventricular dysfunction: implications of recent therapeutic trials and future directions for therapy.
Pitt B
Schweiz Med Wochenschr; 1993 Feb; 123(8):342-8. PubMed ID: 8095738
[TBL] [Abstract][Full Text] [Related]
16. Contemporary Drug Development in Heart Failure: Call for Hemodynamically Neutral Therapies.
Vaduganathan M; Butler J; Pitt B; Gheorghiade M
Circ Heart Fail; 2015 Jul; 8(4):826-31. PubMed ID: 26199309
[No Abstract] [Full Text] [Related]
17. Current and ongoing randomized trials in heart failure and left ventricular dysfunction.
Garg R; Yusuf S
J Am Coll Cardiol; 1993 Oct; 22(4 Suppl A):194A-197A. PubMed ID: 8104204
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of Renin-Angiotensin-aldosterone blockade for heart failure in presence of preserved left ventricular function.
Meune C; Wahbi K; Duboc D; Weber S
J Cardiovasc Pharmacol Ther; 2011; 16(3-4):368-75. PubMed ID: 21193681
[TBL] [Abstract][Full Text] [Related]
19. [Changing views on the place of drugs in the treatment of chronic heart failure].
Sidorenko BA; Preobrazhenskiĭ DV
Kardiologiia; 2005; 45(3):90-1. PubMed ID: 15821722
[No Abstract] [Full Text] [Related]
20. Efficacy of coenzyme Q10 in patients with cardiac failure: a meta-analysis of clinical trials.
Lei L; Liu Y
BMC Cardiovasc Disord; 2017 Jul; 17(1):196. PubMed ID: 28738783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
